[1] Covelli C, Sacchi D, Sarcognato S, et al. Pathology of autoimmune hepatitis. Pathologica, 2021, 113(3): 185-193. [2] Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31(5): 929-938. [3] Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology, 2008, 48(1): 169-176. [4] 中华医学会肝病学分会. 自身免疫性肝炎诊断和治疗指南(2021年). 中华内科杂志, 2021, 60(12): 1038-1049. [5] Komori A. Recent updates on the management of autoimmune hepatitis. Clin Mol Hepatol, 2021, 27(1): 58-69. [6] Harada K, Hiep NC, Ohira H. Challenges and difficulties in pathological diagnosis of autoimmune hepatitis. Hepatol Res, 2017, 47(10): 963-971. [7] Laschtowitz A, Zachou K, Lygoura V, et al. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. JHEP Rep, 2021, 3(4): 100321-100321. [8] Lohse AW, Chazouillères O, Dalekos G, et al. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol, 2015, 63(4): 971-1004. [9] Hartl J, Ehlken H, Sebode M, et al. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. J Hepatol, 2018, 68(4): 754-763. [10] Li Y, Yan L, Wang R, et al. Serum immunoglobulin G levels predict biochemical and histological remission of autoimmune hepatitis type 1: a single-center experience and literature review. Clin Rev Allergy Immunol, 2022, 62(2): 292-300. [11] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年). 实用肝脏病杂志, 2019, 22(6): 793-803. [12] Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases. Hepatology, 2020, 72(2): 671-722. [13] Wang G, Tanaka A, Zhao H, et al. The Asian Pacific association for the study of the liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int, 2021, 15(2): 223-257. [14] Hartl J, Miquel R, Zachou K, et al. Features and outcome of AIH patients without elevation of IgG. JHEP Rep, 2020, 2(3): 100094-100094. [15] Lohse AW, Sebode M, Bhathal PS, et al. Consensus recommendations for histological criteria of autoimmune hepatitis from the international AIH pathology group: results of a workshop on AIH histology hosted by the European reference network on hepatological diseases and the European society of pathology. Liver Int, 2022, 42(5): 1058-1069. [16] 苗琪, 陈晓宇. 自身免疫性肝炎的肝组织病理学诊断. 临床肝胆病杂志, 2020, 36(04): 728-730. [17] Sucher E, Sucher R, Gradistanac T, et al. Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies. J Immunol Res, 2019, 2019(2019): 9437043. [18] 龙梅, 王丽旻, 朱莉, 等. 自身免疫性肝炎患者临床和肝组织病理学特征. 实用肝脏病杂志, 2020, 23(1): 142-143. [19] Tasneem AA, Luck NH. Autoimmune hepatitis: clinical characteristics and predictors of biochemical response to treatment. J Transl Int Med, 2020, 8(2): 106-111. [20] Tiniakos DG, Brain JG, Bury YA. Role of histopathology in autoimmune hepatitis. Dig Dis, 2015, 33(Suppl 2): 53-64. |